Skip to main content
SpringerLink
Log in
Book cover

Minimally Invasive Surgery in Orthopedics pp 393–414Cite as

Minimally Invasive Treatments for Dupuytren Contracture

  • Reference work entry
  • First Online:

  • 127 Accesses

Abstract

Dupuytren disease is a benign inherited fibromatosis of the fascia of the hand and fingers. It leads to progressive contracture, which alters hand function. There is no known “cure” for Dupuytren contracture.

Dupuytren contracture is traditionally treated with open surgical procedures, most commonly partial palmar fasciectomy. There are numerous problems associated with open fasciectomy. Regional or general anesthesia is often required. Recurrence rates vary from 12 % to 73 % and there is a significant complication rate reported between 3.9 % and 39 %. It is common for patients to require an extended period out of work and away from sports and an extensive course of postoperative hand therapy is often necessary. Even after meticulous removal of diseased fascia, the disease and contracture can recur.

Needle aponeurotomy (NA/PNF) and Clostridium Histolyticum Collagenase (CCH, Xiaflex, Xiapex) injection are new minimally invasive methods used to treat Dupuytren contracture. Compared to fasciectomy, they have a lower complication rate and recovery is more rapid. Patients can return to work and sports more quickly. These procedures can be performed under local anesthesia in an office or clinic setting. The overall cost is lower; however, recurrence rates are higher than with open surgery.

This chapter examines the history of minimally invasive treatment and the anatomy and physical examination of the pathological cords. Reported outcomes, efficacy, and recurrence rates are reviewed. Precise step-by-step techniques for performing NA and CCH are presented. Emphasis is placed on accuracy, maximizing correction, and minimizing potential complications. Tips and pearls from the author’s greater than 10-year experience are discussed.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   899.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   1,199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Ling R. The genetic factor in Dupuytren’s disease. J Bone Joint Surg Br. 1963;45:709–18.

    CAS  PubMed  Google Scholar 

  2. Swartz WM, Lalonde DH. Dupuytren’s disease. Plast Reconstr Surg. 2008;121(4):1–10.

    Article  PubMed  Google Scholar 

  3. Ross D. Epidemiology of Dupuytren’s contracture. Hand Clin. 1999;15:53–62.

    CAS  PubMed  Google Scholar 

  4. Bayat A, Cunliffe EJ, McGrouther DA. Assessment of clinical severity in Dupuytren’s disease. Br J Hosp Med. 2007;68:604–9.

    Article  CAS  Google Scholar 

  5. Hindicha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren’s disease incidence and prevalence rates in relation to etiology. Hand. 2009;4:256–69.

    Article  Google Scholar 

  6. DiBenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X. Prevalence, incidence and treatments of Dupuytren’s disease in the United States: results from a population-based study. Hand. 2011;6:149–58.

    Article  PubMed  Google Scholar 

  7. Leclerq C. Non-surgical treatment. In: Tubiana R, Leclerq C, Hurst L, Badalamente MA, Macklin EJ, editors. Dupuytren’s disease. London: Martin Dunitz; 2000.

    Google Scholar 

  8. McFarlane R. Some observations on the epidemiology of Dupuytren’s disease. In: Hueston J, Tubiana R, editors. Dupuytren’s disease, GEM’s monographs. 2nd ed. Edinburgh: Churchill Livingstone; 1985. p. 122–6.

    Google Scholar 

  9. Trojian TH, Chu SM. Dupuytren’s disease: diagnosis and treatment. Am Fam Physician. 2007;76:86–9.

    PubMed  Google Scholar 

  10. Dohlem T. On permanent retraction of the fingers, according to Dupuytren. Rev Rhum Engl Ed. 1996;63:435–43.

    CAS  PubMed  Google Scholar 

  11. Hueston JT. Dupuytren’s contracture. Edinburgh: E&S Livingstone; 1963.

    Google Scholar 

  12. Hueston JT. State of the art: the management of recurrent Dupuytren’s disease. Eur Med Bibliogr. 1991;1:4–7.

    Google Scholar 

  13. Abe Y, Rokkaku T, Ofuchi W, et al. An objective method to evaluate the risk of recurrence and extension of Dupuytren’s disease. J Hand Surg (Br). 2004;29(5):427–30.

    Article  CAS  Google Scholar 

  14. Hindocha S, Stanley JK, Watson S, et al. Dupuytren’s diathesis revisited: evaluation of prognostic factors for risk of disease recurrence. J Hand Surg (Am). 2006;31(10):1626–34.

    Article  Google Scholar 

  15. Cline H. Notes on pathology. London: St. Thomas Manuscript Collection; 1777. p. 185.

    Google Scholar 

  16. Cooper A. A treatise on dislocations and on fractures of the joints. 2nd ed. London: Longman, Hurst; 1823. p. 570–6.

    Google Scholar 

  17. Adams W. On contractions of the fingers (Dupuytren and congenital contractions) and hammer-toe. London: Churchill; 1892.

    Google Scholar 

  18. Goyrand G. Nouvelles recherches sur la retraction permanente des doight. Gaz Med Paris. 1883;3:481–6.

    Google Scholar 

  19. Fergusson W. A system of practical surgery. London: Churchill; 1842.

    Google Scholar 

  20. Luck JV. Dupuytren’s contracture. A new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am. 1959;41:635–64.

    PubMed  Google Scholar 

  21. Lermusiaux JL, Debeyre N. Le traitement medical de la malidie de Dupuytren, Rhumatologique. Paris: Expansion Scietifique; 1979. p. 338–43.

    Google Scholar 

  22. Badois FJ, Lermusiaux C, Masse C, Kuntz D. Nonsurgical treatment of Dupuytren disease using needle fasciotomy. Rev Rhem (Engl Ed). 1993;60:692–7.

    Google Scholar 

  23. Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg. 2003;28B:427–31.

    Article  Google Scholar 

  24. van Rijssen AL, Werker PN. Percutaneous needle fasciotomy in Dupuytren disease. J Hand Surg. 2006;31B:498–501.

    Google Scholar 

  25. Eaton C. Percutaneous fasciotomy for Dupuytren contracture. J Hand Surg. 2011;36A:910–5.

    Article  Google Scholar 

  26. Pess GM, Pess RM, Pess RA. Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers. J Hand Surg (Am). 2012;37A:651–6.

    Article  Google Scholar 

  27. Diaz R, Curtin C. Needle aponeurotomy for the treatment of Dupuytren’s disease. Hand Clin. 2014;30:33–8.

    Article  PubMed  Google Scholar 

  28. Morhart M. Pearls and pitfalls of needle aponeurotomy in Dupuytren’s disease. Plast Reconstr Surg. 2014;135:817–25.

    Article  Google Scholar 

  29. McMillan C, Binhammer P. Steroid injection and needle aponeurotomy for Dupuytren disease: long term follow-up of a randomized controlled trial. J Hand Surg (Am). 2014;39(10):1942–7.

    Article  Google Scholar 

  30. Badalamente MA, Hurst LC. Enzyme injection as a nonoperative treatment for Dupuytren’s disease. Drug Deliv. 1996;3:35–40.

    Article  Google Scholar 

  31. Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren’s contracture. J Hand Surg (Am). 2007;32:767–74.

    Article  Google Scholar 

  32. Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, Smith TM, Rodzvilla J. Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med. 2009;361:968–79.

    Article  CAS  PubMed  Google Scholar 

  33. Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N. Injectable collagenase clostridium histolyticum: a new nonsurgical treatment for Dupuytren’s disease. J Hand Surg (Am). 2010;35(12):2027–38.

    Article  Google Scholar 

  34. Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren’s disease. J Hand Surg (Am). 2010;35(4):534–9.

    Article  Google Scholar 

  35. Witthaut J, Jones G, Skrepnik N, Kushner H, Houston A, Lindau T. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren’s contracture: short-term results from 2 open-label studies. J Hand Surg (Am). 2013;38(1):2–11.

    Article  Google Scholar 

  36. Peimer CA, Blazar P, Coleman S, Kaplan FT, Smith T, Tursi JP, Cohen B, Kaufman GJ, Lindau T. Dupuytren’s contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg (Am). 2013;38(1):12–22.

    Article  Google Scholar 

  37. Gaston G, Larsen SE, Pess GM, Coleman S, Dean B, Cohen BM, Kaufman GJ, Tursi JP, Hurst LC. The efficacy and safety of concurrent collagenase clostridium histolyticum injections for two Dupuytren contractures in the same hand, a prospective multicenter center. J Hand Surg (Am). 2015;40:1963–1971.

    Google Scholar 

  38. Seegenschmiedt MH, Keilholz L, Wielputz M, Schubert C, Fehlauer F. Long term outcome of radiotherapy for early stage Dupuytren’s disease: a phase III clinical study. In: Eaton C, Seegenschmiedt MH, Bayat A, Gabbiani G, Werker P, Wach W, editors. Dupuytren’s disease and related hyperproliferative disorders: principals, research and clinical perspectives. Berlin: Spring-Verlag; 2012. p. 349–71.

    Chapter  Google Scholar 

  39. Ketchum LD, Donahue TK. The injection of nodules of Dupuytren’s disease with triamcinolone acetonide. J Hand Surg. 2000;25(6):1157–62.

    Article  CAS  Google Scholar 

  40. McMillan C, Binhammer P. Steroid injection and needle aponeurotomy for Dupuytren disease: a randomized controlled study. J Hand Surg (Am). 2012;37(7):1307–12.

    Article  PubMed  Google Scholar 

  41. McIndoe A, Beare RLB. The surgical management of Dupuytren’s contracture. Am J Surg. 1958;95:197–203.

    Article  CAS  PubMed  Google Scholar 

  42. McCash CR. The open palm technique in Dupuytren’s contracture. Br J Plast Surg. 1964;17:271–80.

    Article  CAS  PubMed  Google Scholar 

  43. Gelberman RH, Amiel D, Rudolph RM, Vance RM. Dupuytren contracture. An electron microscopic, biochemical, and clinical correlative study. J Bone Joint Surg Am. 1980;62:425–32.

    CAS  PubMed  Google Scholar 

  44. Hueston JT. Dermofasciectomy for Dupuytren’s disease. Bull Hosp Jt Dis. 1984;44:224–32.

    CAS  Google Scholar 

  45. Ketchum LD, Hixson FP. Dermofasciectomy and full-thickness grafts in the treatment of Dupuytren’s contracture. J Hand Surg [Am]. 1987;12:659–63.

    Article  CAS  Google Scholar 

  46. Dias JJ, Braybrooke J. Dupuytren contracture: an audit of the outcomes of surgery. J Hand Surg. 2006;31B:514–21.

    Article  Google Scholar 

  47. Ullah AS, Dias JJ, Bhowal B. Does a ‘firebreak’ full-thickness skin graft prevent recurrence after surgery for Dupuytren contracture?: a prospective, randomised trial. J Bone Joint Surg (Br). 2009;91:374–8.

    Article  CAS  Google Scholar 

  48. Hurst LC, Wolfe SW, Hotchkiss RN, Pederson WC, Kozin SH. Dupuytren’s contracture. In: Hurst LC, editor. Green’s Operative Hand Surgery. 6th ed. Philadelphia: Elsevier Churchill Livingstone; 2011. p. 141–58.

    Chapter  Google Scholar 

  49. Denkler K. Surgical complications associated with fasciectomy for Dupuytren’s disease: a 20-year review of the English literature. Plast Surg. 2010;10:116–33.

    Google Scholar 

  50. Donga P, DeKoven M, Kaplan FT, Tursi JP, Lee WC. Costs of collagenase clostridium histolyticum and fasciectomy for Dupuytren’s contracture. Am J Pharm Benefits. 2015;7(1):24–31.

    Google Scholar 

  51. Bayat A, McGrouther DA. Management of Dupuytren’s disease–clear advice for an elusive condition. Ann R Coll Surg Engl. 2006;88(1):3–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Henry M. Dupuytren’s disease: current state of the art. Hand. 2014;9:1–8.

    Article  PubMed  Google Scholar 

  53. Skirven TM, Bachoura A, Jacoby SM, Culp RW, Osterman AL. The effect of a therapy protocol for increasing correction of severely contracted proximal interphalangeal joints cause by Dupuytren disease and treated with collagenase injection. J Hand Surg. 2013;38(4):684–9.

    Article  Google Scholar 

  54. Werker PMN, Pess GM, van Rijssen AL, Denkler K. Correction of contracture and recurrence rates of Dupuytren contracture following invasive treatment: the importance of clear definitions. J Hand Surg. 2012;37(10):2095–105.

    Article  Google Scholar 

  55. Felici N, Marcoccio I, Giunta R, Haerle M, Leclercq C, Pajardi G, Willebrand S, Georgescu AV, Pess G. Dupuytren contracture recurrence project: reaching consensus on a definition of recurrence. Handchir Mikrochir Plast Chir. 2014;46:350–354.

    Article  CAS  PubMed  Google Scholar 

  56. Bleton R, Marcireau D, Almot JY. Treatment of Dupuytren disease by percutaneous needle fasciotomy. In: Saffer P, Amadio PC, Foucher G, editors. Current practice in hand surgery. London: Martin Dunitz; 1997. p. 187–93.

    Google Scholar 

  57. Lermusiaux JL, Lellouche H, Badois F, Kuntz D. How should Dupuytren contracture be managed in 1997? Rev Rhum Engl Ed. 1997;64:775–6.

    CAS  PubMed  Google Scholar 

  58. van Rijssen AL, Linden H, Werker PN. Five-year resultrs of a randomized clinical trial on treatment of Dupuytren’s disease: Percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012;129:469–77.

    Article  PubMed  Google Scholar 

  59. Meals RA, Hentz VR. Technical tips for collagenase injection treatment for Dupuytren contracture. J Hnad Surg (Am). 2014;39(6):1195–200.

    Article  Google Scholar 

  60. Peimer CA, Skodny P, Mackowiak JI. CCH for Dupuytren contracture: Patterns of use and effectiveness in clinical practice. J Hand Surg. 2013;38(12):2370–6.

    Article  Google Scholar 

  61. Peimer CA, Blazar P, Coleman S, Kaplan FT, Smith T, Lindau T. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS [collagenase option for reduction of Dupuytren long-term evaluation of safety study]): 5-year data. J Hand Surg (Am). 2015. doi:10.1016/j.jhsa.2015_04_036 (Epub).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery, Central Jersey Hand Surgery, Drexel University School of Medicine, 13 Pal Drive Wayside, NJ, 07712, USA

    Gary M. Pess

Authors
  1. Gary M. Pess
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gary M. Pess .

Editor information

Editors and Affiliations

  1. Orthopedic Service Line, Northwell Health , New York, New York, USA

    Giles R. Scuderi

  2. Department of Orthopedic Surgery, Rutgers-Robert Wood JohnsonMedicalSchool Department of Orthopedic Surgery, New Brunswick, New Jersey, USA

    Alfred J. Tria

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this entry

Cite this entry

Pess, G.M. (2016). Minimally Invasive Treatments for Dupuytren Contracture. In: Scuderi, G., Tria, A. (eds) Minimally Invasive Surgery in Orthopedics. Springer, Cham. https://doi.org/10.1007/978-3-319-34109-5_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-34109-5_40

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-34107-1

  • Online ISBN: 978-3-319-34109-5

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation